Health Care & Life Sciences » Biotechnology | Eastwood Bio-Medical Canada Inc.

Eastwood Bio-Medical Canada Inc. | Income Statement

Fiscal year is November-October. All values CAD Thousands.
2015
2016
2017
2018
Sales/Revenue
1,186.10
463.90
479.70
744
Cost of Goods Sold (COGS) incl. D&A
1,025.50
534.20
547.80
386.90
Gross Income
160.60
70.20
68.00
357.10
SG&A Expense
442.10
437.30
520.20
923
EBIT
-
507.50
588.30
565.90
Non Operating Income/Expense
7.00
6.00
7.60
3.80
Interest Expense
1.80
1.10
1.40
1.30
Pretax Income
260.40
468.50
489.60
862
Consolidated Net Income
260.40
468.50
489.60
862
Net Income
260.40
468.50
489.60
862
Net Income After Extraordinaries
260.40
468.50
489.60
862
Net Income Available to Common
260.40
468.50
489.60
862
EPS (Basic)
0.00
0.01
0.01
0.01
Basic Shares Outstanding
67,356.00
67,356.00
67,502.70
68,886
EPS (Diluted)
0.00
0.01
0.01
0.01
Diluted Shares Outstanding
67,356.00
67,356.00
67,502.70
68,886
EBITDA
281.40
507.50
588.30
540.30
Non-Operating Interest Income
29.80
46.10
92.50
78.40

About Eastwood Bio-Medical Canada

View Profile
Address
4871 Shell Road
Richmond British Columbia V6X 3Z6
Canada
Employees -
Website http://www.eleotin.ca
Updated 07/08/2019
Eastwood Bio-Medical Canada, Inc. is engaged in the business of marketing and distributing natural health products in North America. It is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. Its products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.